Search Results

Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies.

• Authors : Wynne, Chris¹ (AUTHOR); Balgos, Abundio² (AUTHOR); Li, Jingxin³ (AUTHOR)

Subjects: *COVID-19 vaccines; *IMMUNE response; *SAFETY

• Source: Infectious Diseases & Therapy. Jul2024, Vol. 13 Issue 7, p1723-1724. 2p.

Record details

Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies.

• Authors : Wynne, Chris¹ (AUTHOR); Balgos, Abundio² (AUTHOR); Li, Jingxin³ (AUTHOR)

• Source: Infectious Diseases & Therapy. Jan2024, Vol. 13 Issue 1, p57-78. 22p.

Record details

Isolated port‐site prostate metastasis after robot‐assisted laparoscopic radical prostatectomy.

• Authors : Teo, Keith¹ (AUTHOR); Wynne, Chris² (AUTHOR); Bax, Kevin³ (AUTHOR)

Subjects: *METASTASIS; *PROSTATE; *PROSTATE cancer

• Source: ANZ Journal of Surgery. Oct2019, Vol. 89 Issue 10, pE443-E444. 2p. 2 Color Photographs, 1 Diagram.

Record details

Reply to: Letter to the editor 'Subcutaneous herceptin therapy'.

• Authors : Wynne, Chris¹; Harvey, Vernon²; Schwabe, Christian²

Subjects: *OBESITY complications; *BREAST tumors; *HEALTH outcome assessment

• Source: Journal of Clinical Pharmacology. Dec2013, Vol. 53 Issue 12, p1343-1344. 2p.

Record details

Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial.

• Authors : Wynne, Chris¹ (AUTHOR); Schwabe, Christian² (AUTHOR); Vincent, Emmanuelle³ (AUTHOR)

• Source: Pharmacology Research & Perspectives. Apr2020, Vol. 8 Issue 2, p1-9. 9p.

Record details

A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin®) in Healthy Male Subjects.

• Authors : Wu, Xiaoyun¹ (AUTHOR); Wynne, Chris² (AUTHOR); Xu, Chenchao¹ (AUTHOR)

Subjects: *BEVACIZUMAB; *PHARMACOKINETICS; *CLINICAL trials

• Source: BioDrugs. Jun2019, Vol. 33 Issue 3, p335-342. 8p.

Record details

Representation of 3-D elevation in terrain databases using hierarchical triangulated irregular networks: a comparative analysis.

• Authors : Abdelguerfi, Mahdi; Wynne, Chris; Cooper, Edgar

Subjects: *TRIANGULATION; *RELIEF models; *TOPOGRAPHICAL surveying

• Source: International Journal of Geographical Information Science. Dec98, Vol. 12 Issue 8. 4 Black and White Photographs, 29 Diagrams, 2 Charts, 1 Cartoon or Caricature.

Record details

A comparative pharmacokinetic study of DRL_BZ, a candidate biosimilar of bevacizumab, with Avastin® (EU and US) in healthy male subjects.

• Authors : Wynne, Chris¹; Schwabe, Christian²; Batra, Sonica Sachdeva³

Subjects: *BEVACIZUMAB; *PHARMACOKINETICS; *MONOCLONAL antibodies

• Source: British Journal of Clinical Pharmacology. Oct2018, Vol. 84 Issue 10, p2352-2364. 13p. 1 Diagram, 5 Charts, 2 Graphs.

Record details

A prospective clinical study of cerebral microemboli and neuropsychological outcome comparing vent-line and auto-venting arterial line filters: both filters are equally safe.

• Authors : Whitaker, Donald C.¹; Stygall, Jan¹; Hope-Wynne, Chris²

Subjects: *BEHAVIORAL toxicology; *CARDIAC surgery; *CORONARY artery bypass

• Source: Perfusion. Mar2006, Vol. 21 Issue 2, p83-86. 4p. 3 Charts.

Record details

Comparative pharmacokinetics of subcutaneous trastuzumab administered via handheld syringe or proprietary single-use injection device in healthy males.

• Authors : Wynne, Chris¹ ; Ellis-Pegler, Rod²; Waaka, Devonie¹

Subjects: *DISPOSABLE medical devices; *PHARMACOKINETICS; *COMPARATIVE studies

• Source: Cancer Chemotherapy & Pharmacology. Nov2013, Vol. 72 Issue 5, p1079-1087. 9p.

Record details